Loading [Contrib]/a11y/accessibility-menu.js
JHEOR
Menu
Articles
Author Correction
Autoimmune Diseases
Brief Report
Cardiovascular Conditions
Commentary
Correspondence
Dermatological Diseases
Endocrine Diseases
Gastrointestinal Conditions
General Indications
Hematology
Hereditary Genetic Disorders
Infectious Diseases
Methodology and Healthcare Policy
Nephrologic/Hepatologic Conditions
Neurological Diseases
Oncology
Ophthalmology
Other Conditions
Perspective
Psychological Conditions
Respiratory Diseases
Trauma Induced Conditions
Urological/Gynecological Diseases
All
For Authors
Editorial Board
About
Issues
Blog
Journal Policies
For Reviewers
search
Sorry, something went wrong. Please try your search again.
×
Articles
Blog posts
RSS Feed
Enter the URL below into your favorite RSS reader.
https://jheor.org/feed
×
Autoimmune Diseases
Vol. 3, Issue 2, 2016
September 17, 2015 EDT
Biologic Cost per Effectively Treated Rheumatoid Arthritis Patient in a Large Managed Care Population: A Retrospective Cohort Study
Tao Gu
,
Neel Shah
,
Gaurav Deshpande
,
Derek H. Tang
,
Debra F. Eisenberg
,
David J. Harrison
,
managed care
cost
effectiveness
biologics
rheumatoid arthritis
Copyright Logo
ccby-4.0
•
https://doi.org/10.36469/9830
JHEOR
1.
Gu T, Shah N, Deshpande G, Tang DH, Eisenberg DF, Harrison DJ. Biologic Cost per Effectively Treated Rheumatoid Arthritis Patient in a Large Managed Care Population: A Retrospective Cohort Study.
JHEOR
. 2015;3(2):122-131.
doi:10.36469/9830
Save article as...
▾
PDF
XML
Citation (BibTeX)
View more stats